Asthma in the elderly and senile age: features of diagnosis and treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In the developed countries of the world, an increase in the life expectancy of the population has led to an increase in the number of elderly and senile patients suffering from asthma. Literature data and the results of own authors’studies indicate that patients older than 60 years more often have a more severe course of asthma, fixed bronchial obstruction, a low level of disease control and a reduced quality of life than younger patients. Difficulties in the diagnosis of asthma are caused by a decrease in the patient’s perception of the symptoms of the disease and multimorbidity. In this regard, a qualitative study of lung function with a test for obstruction reversibility is of great importance. Hypodiagnosis of asthma is one of the reasons for its inadequate treatment. In the management of patients, their education, taking into account concomitant diseases, drug interactions and side effects of drugs play an important role.

Full Text

Restricted Access

About the authors

Aleksandr V. Emelyanov

North-Western State Medical University n.a. I.I. Mechnikov

Email: emelav@inbox.ru
Department of Pulmonology; Dr. Sci. (Med.), Professor, Head of the Department of Pulmonology 41, Kirochnaya str., St. Petersburg 191015, Russian Federation

E. V Leshenkova

North-Western State Medical University n.a. I.I. Mechnikov

Department of Pulmonology St. Petersburg, Russia

G. R Sergeeva

North-Western State Medical University n.a. I.I. Mechnikov

Department of Pulmonology St. Petersburg, Russia

References

  1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691-706. doi: 10.1016/S2213-2600(17)30293-X.
  2. Battaglia S., Benfante A., Spatafora M., Scichilone N. Asthma in the elderly: a different disease? Breathe. 2016;12:18-28. doi: 10.1183/20734735.002816.
  3. Oraka E., Kim H.J., King M.E., et al. Asthma prevalence among US elderly by age groups: age still matters. J Asthma. 2012;49:593-99. Doi: 103109/02770903.2012.684252.
  4. Wilson D., Appleton S.L., Adams R.J., Ruffin R.E. Underdiagnosed asthma in older people: an underestimated problem. MJA. 2005;183:20-2.
  5. Yanez A., Cho S.-H., Soriano J.B., et al. Asthma in the elderly: what we know and what we have to know. WAO J. 2014;7:8. doi: 10.1186/1939-4551-7-8.
  6. Nair P., Ho T. Challenges of managing asthma in an elderly population. Pol Arch Inter Med. 2017;127(4):291-93. doi: 10.20452/pamw.4011.
  7. Федосеев Г.Б., Емельянов А.В., Сергеева Г.Р. и др. Распространенность бронхиальной астмы и аллергического ринита среди взрослого населения Санкт-Петербурга. Терапевтический архив. 2003;759(1):23-6
  8. Enright P.L., McCleland R.L., Newman A.B., et al. Underdiagnosis and treatment of asthma in the elderly. Cardiovasc Health Study Research Group. Chest. 1999;116:606-13. doi: 10.1378/chest.116.3.603.
  9. Whiters N.J., Vilar T., Dow L. Asthma in elderly: diagnostic and therapeutic considerations. Difficult asthma. Ed. S. Holgate, H.A. Boushley, Fabri L.-Martin Dunitz. Ltd. 1999. Р 147-62.
  10. Dow L. Asthma in older people. Clin Exp Allergy. 1998;28(Suppl. 5):195-202. doi: 10.1046/j.1365-2222.1998.028s5195.x.
  11. Enright P.L. The diagnosis of asthma in older patients. Exp Lung Res. 2005;31(Suppl. 1):15-21.
  12. Slavin R.G. The elderly asthmatic patient. Allergy Asthma Proc. 2004;25(6)371-73.
  13. Weiner P., Magadle R., Waizman J., et al. Characteristics of asthma in elderly. Eur Respir J. 1998;12:564-68. doi: 10.1183/09031936.98.12030564.
  14. Allen S.C., Khattab A. The tendency to alter perception of airflow resistance in aged subjects might be due to mainly to a reduction in diaphragmatic proprioception. Med Hypothesis. 2006;67(6):1406-10. doi: 10.1016/j.mehy. 2006.05.046.
  15. Батагов С.Я., Трофимов В.И., Немцов В.И. и др. Особенности своеобразия проявлений бронхиальной астмы в гериатрическом возрасте. Пульмонология. 2003;2:38-42.
  16. Baptist A.P., Busse P.J. Asthma Over the Age of 65: All's Well That Ends Well. J Allergy Clin Immunol. In Practice. 2018;6(3):764-73. doi: 10.1016/j.jaip.2018.02.007.
  17. Barnard A., Pond C.D., Usherwood TP Asthma and older people in general practice. MJA. 2005; 183:41-3.
  18. Soriano J.B., Visick G.T., Muellerova H., et al. Pattern of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099-107. doi: 10.1378/chest.128.4.2099.
  19. Bozek A., Rogala B., Bednarski P Asthma, COPD and comorbidities in elderly people. J Asthma. 2016;26:1-5. doi: 10.3109/02770903.2016.1170139.
  20. Su X., Ren Y., Li M., et al. Prevalence of comorbidities in asthma and nonasthma patients: a meta-analysis. Med. (Baltimore). 2016;95:e3459. doi: 10.1097/MD.0000000000003459.
  21. British guideline on the management of asthma. A national clinical guideline. Revised. 2019. Available at: http://www.brit-thoracic.org.uk. Access 05.04.2020.
  22. Global Initiative for asthma. NHLB/WHO Workshop Report. National Heart Lung Blood Institute, updated 2020//www.ginasthma.org. Access 07.04.2020.
  23. Yanez A., Cho S.-H., Soriano J.B., Rosenwasser L.J., Rodrigo G.J., Rabe K.F., et al. Asthma in elderly: what we know and what we have yet to know. World Allergy Organ J. 2014;7:8. doi: 10.1186/1939-4551-7-8.
  24. Inoue H., Niimi A., Takeda T., et al. Pathophysiological characteristics of asthma in the elderly: a comprehensive study. Ann. Allergy Asthma Immunol. 2014;113(5):527-33. doi: 10.1016/j.anai.2014.08.002.
  25. Bennett G.H., Carpenter L., Hao W., Song P., Steinberg J., Baptist A.P Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma. Ann Allergy, Asthma Immunol. 2018;120(2):164-68.e1. doi: 10.1016/j.anai.2017.10.004.
  26. Sin B.A., Akkoca O., Saryal S., et al. Differences between asthma and COPD in elderly. J Investig Allergol Clin Immunol. 2006;16(1):44-50.
  27. Gershon A.S., Victor J.C., Guan J., et al. Pulmonary function testing in the diagnosis of asthma: a population study. Chest. 2012;141:1190-96. doi: 10.1378/chest.11-0831.
  28. Bellia V., Pistelli R., Catalano F., et al. Quality control of spirometry in the elderly. The SA.R.A. study. SAlute Respiration nell'Anziano=Respiratory Health in the Elderly. Am J Respir Crit Care Med. 2000;161:1094-100. doi: 10.1164/ajrccm.161.4.9810093.
  29. Haynes J.M. Pulmonary function test quality in the elderly: a comparison with younger adults. Respir Care. 2014;59:16-21. doi: 10.4187/respcare.02331.
  30. Dweik R.A., Boggs P.B., Erzurum S.C., et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications. Am J Respir Crit Care Med. 2011;184:602-15. doi: 10.1164/rccm.9120-11ST
  31. Huss K., Naumann P.L., Mason P.J., et al. Asthma severity, atopic status, allergen exposure, and quality of life in elderly persons. Ann. Allergy Asthma Immunol. 2001;86:524-30. doi: 10.1016/S1081-1206(10)62900-6.
  32. Lombardi C., Raffetti E., Caminati M., et al. Phenotyping asthma in the elderly: allergic sensitization profile and upper airways comorbidity in patients older than 65 years. Ann Allergy Asthma Immunol. 2016;116(3):206-11. doi: 10.1016/j.anai.2015.12.005.
  33. Busse P.J., Cohn R.D., Salo P.M., Zeldin D.C. Characteristics of allergic sensitization among asthmatic adults older than 55 years: results from the National Health and Nutrition Examination Survey, 2005-2006. Ann Allergy Asthma Immunol. 2013;110:247-52. doi: 10.1016/j.anai.2013.01.016.
  34. Ozturk A.B, Iliaz S. Challenges in the management of severe allergic asthma in the elderly. J Asthma Allergy. 2016;9:55-63. doi: 10.2147/JAA.S85420.
  35. Sano H., Iwanaga T., Nishiyama O., et al. Characteristics of phenotypes of elderly patients with asthma. Allergol Inter. 2016;65:204-9. doi: 10.1016/j.alit.2015.11.007.
  36. Tamada T., Sugiura H., Takahashi T., et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169-76. doi: 10.2147/COPD.S88274.
  37. Marks G.B., Poulos L. A national perspective on asthma in older Australians. MJA. 2005;183:14-6.
  38. Why asthma still kills. The National Review of Asthma Deaths (NRAD) Confidential Enquiry report (May 2014). www.rcplondon.ac.uk/nrad. Access 05.04.2020.
  39. Ross J.A.,Yang Y., Song P.X.K., et al. Quality of Life, Health Care Utilization, and Control in Older Adults with Asthma. J Allergy Clin Immunol. In Practice. 2013;1:157-62. doi: 10.1016/j.jaip.2012.12.003.
  40. Hira D., Komase Y., Koshiyama S., et al. Problems of elderly patients on inhalation therapy: Difference in problem recognition between patients and medical professionals. Allergol Inter. 2016. doi: 10.1016/j.alit.2016.04.002.
  41. Molimard M., Le Gros V., Robinson P., Bourdeix I. Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting. J Aerosol Med Pulm Drug Deliv. 2010;23:91-5. doi: 10.1089/jamp.2009.0762.
  42. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001;107(6):937-44. doi: 10.1067/mai.2001.115653.
  43. Sin D.D., Man J., Sharpe H., et al. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA. 2004;292(3):367-76. doi: 10.1001/jama.292.3.367.
  44. O'Byrne P.M., FitzGerald J.M., Lamarca R., et al. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N EnglJ Med. 2018;378(20):1865-76. doi: 10.1056/NEJMoa17152 74.
  45. Bateman E.D., Reddel H.K., O'Byrne P.M., et al. As-Needed Budesonide-Formoterol versus maintenance Budesonide in Mild asthma. N Engl J Med. 2018;378(20):1877-87. doi: 10.1056/NEJMoa1715275.
  46. Beasley R., Holliday M., Reddel H.K.,et al.; Novel START Study Team. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. N Engl J Med. 2019;380(21):2020-30. doi: 10.1056/NEJMoa1901963.
  47. Schmier J.K., Halpern M.T., Jones M.L. Effects of inhaled corticosteroids on mortality and hospitalization in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence. Drug Aging. 2005;22(9):717-29. doi: 10.2165/00002512-200522090-00001.
  48. O'Burney P.M., Bisgaard H., Godard P.P., et al. Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129-36. doi: 10.1164/rccm.200407-8840C.
  49. Rabe K.F., Atienza T., Magyard P., et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomized controlled, double blind study. Lancet. 2006;368:744-56. doi: 10.1016/S0140-736(06)69284-2.
  50. Haughney J., Aubier M., Jørgensen L., et al. Comparing asthma treatment in elderly versus younger patients. Respir Med. 2011;105(6):838-45. doi: 10.1016/j.rmed.2011.02.011.
  51. Johansson G., Andresson E.B., Larsson P.E., Vogelmeier C.F Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics. 2006;24(7):695-708. doi: 10.2165/00019053-200624070-00008.
  52. Ericsson K., Bantje T.A., Huber R.M., et al. Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. Respir Med. 2006;100(4):586-94. doi: 10.1016/j.rmed.2005.09.032.
  53. Barua P., O'Mahony M.S. Overcoming gaps in the management of asthma in older patients: new insights. Drugs Aging. 2005;22(12):1029-59. doi: 10.2165/00002512-200522120-00004.
  54. Korenblat P.E., Kemp J.P., Scherger J.E., et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol. 2000;84:217-25. doi: 10.1016/S1081-1206(10)62759-7.
  55. Creticos P., Knobil K., Edwards L.D., et al. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. Ann Allergy Asthma Immunol. 2002;88:401-9. doi: 10.1016/S1081-1206(10)62372-1.
  56. Chauhan B.F., Ducharme F.M. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev. 2014;1:CD003137. doi: 10.1002/14651858.CD003137.pub5.
  57. Bozek A., Warkocka-Szoltysek B., Filipowska-Gronska A., Jarzab J. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. J Asthma. 2012;49:530-34. doi: 10.3109/02770903.2012. 680638.
  58. Ye Y.M., Kim S.H., et al; PRANA Group. Addition of montelukast to low-dose inhaled corticosteroid leads to fewer exacerbations in older patients than medium-dose inhaled corticosteroid monotherapy. Allergy Asthma Immunol Res. 2015;7:440-38. doi: 10.4168/aair.2015.7.5.440.
  59. Kerstjens H.A.M., Engel M., Dahl R., et al. Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy. N Engl J Med. 2012;367(13):1198-2007. doi: 10.1056/NEJMoa1208606.
  60. Magnussen H., Bugnas B., van Noord J., et al. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med. 2008;102:50-6. doi: 10.1016/j.rmed.2007.08.003.
  61. Wise R.A., Anzueto A., Cotton D., et al. Tiotropium Respimat Inhaler and the Risk of Death in COPD. N Engl J Med. 2013;369(16):1491-500. doi: 10.1056/NEJMoa1303342.
  62. Van der Hooft C.S., Heeringa J., Brusselie G.G., et al. Corticosteroids and the risk of atrial fibrillation. Arch Inter Med. 2006;166(9):1016-20. doi: 10.1001/archinte.166.9.1016.
  63. Sestini P., Cappiell V, Aliani M., et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol. Med. 2006;19(2):127-36. doi: 10.1089/jam.2006.19.127.
  64. Tunceli O., et al. Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone-Salmeterol Combination for Asthma Management: A United States Retrospective Database Analysis. J Allergy Clin Immunol Pract. 2014;2(6):719-26. doi: 10.1016/j.jaip.2014.07.016.
  65. Gillen М., et al. Effect of a Spacer on Total Systemic and Lung Bioavailability in Healthy Volunteers and in Vitro Performance of the Symbicort® (Budesonide/Formoterol) Pressurized Metered Dose Inhaler. Pulmonary Pharmacology & Therapeutics. 2018;52:7-17. doi: 10.1016/j.pupt.2018.08.001.
  66. Parameswaran K., Hildreth A.J., Chadha D., et al. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med. 1998;92(3):573-77. doi: 10.1016/s0954-6111(98)90311-0.
  67. Sin D.D., Tu J.V. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest. 2001;119(3):720-72. doi: 10.1378/chest.119.3.720.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies